微小RNA-182-5p通过靶向MAPK1调控MAPK/NF-κB通路治疗急性肺损伤的研究

MicroRNA-182-5p regulates the MAPK/NF-κB pathway by targeting MAPK1 to treat acute lung injury

  • 摘要:
      目的  通过分子生物学手段探讨微小RNA-182-5p(miR-182-5p)对脂多糖(LPS)诱导的急性肺损伤(ALI)的影响及其分子机制。
      方法  采用实时荧光定量聚合酶链式反应(qRT-PCR)检测LPS诱导的ALI模型miR-182-5p和丝裂原活化蛋白激酶1(MAPK1)表达。双荧光素酶报告基因检测用于检测miR-182-5p与MAPK1的关系。ALI模型分别给予Ad-MAPK1、Ad-miR-182-5p和Ad-MAPK1+Ad-miR-182-5p, 而后采用苏木精-伊红染色法(HE染色)和Masson染色检测肺损伤指数和肺纤维化改变情况。采用酶联免疫吸附法(ELISA)检测各处理组肺组织中肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)和髓过氧化物酶(MPO)水平。采用蛋白质印迹法(WB)检测核因子κB(NF-κB)和NF-κB抑制蛋白α(IκBα)蛋白表达。
      结果  本研究显示miR-182-5p表达水平在ALI后0~12 h逐渐升高, >12~24 h下降; MAPK1表达则在0~12 h逐渐下降, >12~24 h出现升高。进一步行基因干扰的ALI结果显示, miR-182-5p过表达能够显著下调肺损伤指数、肺纤维化评分和促炎细胞因子水平, 而MAPK1的过表达上调了肺损伤指数、肺纤维化评分和促炎细胞因子水平。体外细胞实验结果显示, LPS刺激显著增加NF-κB的蛋白质表达,同时抑制IκBα的表达。miR-182-5p能够抑制NF-κB的表达而促进IκBα的表达; 相反, MAPK1过表达则逆转了这一现象。
      结论  miR-182-5p通过抑制MAPK/NF-κB信号通路在ALI中发挥治疗作用,本研究数据或可有助于深入了解ALI的潜在分子机制和ALI治疗新方法的开发。

     

    Abstract:
      Objective  To explore the effect of miR-182-5p on lipopolysaccharide (LPS) induced acute lung injury (ALI) and its molecular mechanism through molecular biological methods.
      Methods  Fluorescence quantitative polymerase chain reaction (qRT-PCR) was used to detect the expression of miR-182-5p and MAPK1 in the LPS-induced ALI model. Dual luciferase reporter gene was used to detect the relationship between miR-182-5p and MAPK1. ALI models were treated with Ad-MAPK1, Ad-miR-182-5p and Ad-MAPK1+Ad-miR-182-5p, respectively, and the changes of lung injury index and pulmonary fibrosis were detected by Hematoxylin-eosin staining (HE staining) and Masson staining. The levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and myeloperoxidase (MPO) in lung tissues of all treatment groups were detected by enzyme-linked immunosorbent assay (ELISA). The expressions of nuclear factor κB(NF-κB) and NF-κB inhibitor protein α (IκBα) were detected by western blot (WB).
      Results  This study showed that the expression level of miR-182-5p gradually increased at 0 to 12 hours after ALI, and then decreased at >12 to 24 hours; the expression level of MAPK1 gradually decreased at 0 to 12 hours and increased at >12 to 24 hours. Further genetic interference of ALI showed that the overexpression of miR-182-5p could significantly down-regulate the lung injury index, lung fibrosis and the levels of pro-inflammatory cytokines, while the overexpression of MAPK1 aggravated the levels of lung injury index, lung fibrosis and pro-inflammatory cytokines. Cell experiments in vitro showed that LPS stimulation significantly increased the protein expression of NF-κB and inhibited the expression of IκBα at the same time. The miR-182-5p was able to inhibit the expression of NF-κB and promote the expression of IκBα; on the contrary, the overexpression of MAPK1 reversed this phenomenon.
      Conclusion  MiR-182-5p plays a therapeutic role in ALI by inhibiting the MAPK/NF-κB signaling pathway, and the data of this study may contribute to an in-depth understanding of the potential molecular mechanism of ALI and the development of new therapeutic methods for ALI.

     

/

返回文章
返回